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PENILAIAN PROGRAM PENDIDIKAN KESIHATAN TERAJUI OLEH 
AHLI FARMASI DALAM MENAMBAH BAIK KESIHATAN PESAKIT 
HIPERTENSI BERKAITAN KUALITI HIDUP, PENGETAHUAN TENTANG 
PENYAKIT DAN KEPATUHAN TERHADAP UBAT- UBATAN DI BANDAR 
QUETTA, PAKISTAN 
 
ABSTRAK 
 
Peranan ahli farmasi dalam pengurusan penyakit kronik sudah menjadi suatu norma, 
terutamanya di negara maju. Dalam konteks negara membangun, peranan ahli 
farmasi dalam pengurusan penyakit kronik seperti hipertensi giat diterokai. Justeru, 
matlamat penyelidikan ini adalah untuk menilai impak intervensi ahli farmasi dalam 
pendidikan bagi menambah baik klinikal dan kualiti hidup dalam kalangan pesakit 
hipertensi di Bandar Quetta, Pakistan.  
 
Suatu pendekatan metodologi bercampur yang menggunakan kedua-dua kaedah 
kualitatif dan kuantitatif digunakan dalam penyelidikan ini. Bagi penyelidikan 
kualitatif, 16 orang pesakit hipertensi ditemu bual dan analisis kandungan bertema 
mengenal pasti lima tema utama. Dalam usaha memperoleh gambaran tentang 
pengurusan diri hipertensi, suatu perbincangan kumpulan berfokus dijalankan dengan 
19 orang pesakit hipertensi. Kajian mendapati bahawa strategi pengurusan diri 
dipengaruhi oleh sumber sosial, rakan sebaya atau ahli keluarga dengan sedikit 
maklumat diperoleh daripada profesional penjagaan kesihatan. Latihan pengurusan 
diri mempunyai kaitan yang kuat dengan perbandingan kebaikan dan keburukan 
daripada penggunaan ubat-ubatan dalam jangka panjang.  
 xxiv
Dalam penyelidikan kuantitatif, suatu analisis pra-intervensi daripada pesakit 
hipertensi berkaitan pengetahuan, kepatuhan terhadap penggunaan ubat-ubatan dan 
status semasa daripada Kesihatan berkaitan Kualiti hidup dijalankan dengan 
menggunakan peralatan dan kaedah yang disahkan. Seramai 385 orang pesakit 
hipertensi terlibat dalam ketiga-tiga objektif kajian ini. Analisis ini menunjukkan 
bahawa purata hipertensi berkaitan pengetahuan (skor min 8.03±0.41 daripada 15) 
dengan kesihatan berkaitan kualiti hidup yang tidak baik (skor min 74±28.44 
daripada 100). Kepatuhan terhadap ubat-ubatan juga dilaporkan negatif (skor 
kumulatif daripada -1.74±2.15, berjulat di antara -10 hingga 10).  
 
Fasa penilaian pra-intervensi diikuti dengan pemilihan pesakit kajian secara rawak 
dan melaksanakan intervensi pendidikan. Data pasca intervensi diperoleh daripada 
120 pesakit daripada kumpulan intervensi dan 144 pesakit daripada kumpulan 
kawalan. Hipertensi berkaitan pengetahuan, kepatuhan terhadap penggunaan ubat-
ubatan dan skor Kesihatan berkaitan Kualiti Hidup adalah signifikan (p<0.001) 
apabila dibandingkan di antara kumpulan intervensi dan kumpulan kawalan pada 
penamatan intervensi. Terdapat peningkatan dalam skor min pengetahuan 
(10.26±1.11) dan juga kepatuhan terhadap penggunaan ubat-ubatan (3.24±0.93). 
Namun demikian, dilaporkan bahawa kumpulan intervensi menunjukkan 
pengurangan dalam status kesihatan dibandingkan dengan analisis awalan.  
 
Sebagai kesimpulan, intervensi pendidikan oleh ahli farmasi hospital secara 
signifikannya boleh meningkatkan tahap pengetahuan pesakit tentang hipertensi dan 
membenkan impak yang positif terhadap pematuhan ubat- ubatan. Justeru, peranan 
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ahli farmasi dalam mendidik pesakit hendaklah diterima sebagai bahagian penting 
daripada sistem penjagaan kesihatan. 
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ASSESSMENT OF A PHARMACIST INITIATED HEALTH EDUCATION 
PROGRAMME IN IMPROVING HYPERTENSION PATIENTS' HEALTH 
RELATED QUALITY OF LIFE, DISEASE STATE KNOWLEDGE AND 
MEDICATION ADHERENCE IN QUETTA CITY, PAKISTAN 
 
ABSTRACT 
 
The role of pharmacists in chronic disease state management is becoming a norm 
especially in the developed nations. In developing countries context, the role of 
pharmacists in chronic disease state management such as hypertension is yet to be 
fully explored.  Therefore the aim of this research was to assess the impact of a 
pharmacist led educational intervention for improving clinical and quality of life 
outcomes among hypertensive patients in Quetta city, Pakistan. 
 
A mix methodological approach using both qualitative and quantitative methods was 
used to conduct the research. For the qualitative arm of the research, sixteen 
hypertensive patients were interviewed and thematic content analysis identified five 
major themes.  In order to gain an insight of self management of hypertension, a 
focus group discussion was conducted with 19 hypertensive patients. The study 
found that the self management strategies were influenced by social sources, peers or 
family members with little information received from healthcare professionals. 
Exercise of self-management was strongly linked to the comparative advantages and 
disadvantages of long term medication use.  
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In the quantitative arm of the research, a pre-interventional analysis of patients’ 
hypertension related knowledge, medication adherence and current status of Health 
Related Quality of Life was undertaken using validated tools and methods. A total of 
385 hypertensive patients were included for exploring all the three objectives. The 
pre-interventional analysis revealed average hypertension related knowledge (mean 
score of 8.03±0.41 out of 15) with poor Health Related Quality of Life (mean score 
of 46.74±28.44 out of 100). The medication adherence was also reported negative (a 
cumulative score of -1.74±2.15, ranging from -10 to 10).  
          
The pre-interventional assessment phase was followed by randomization of the study 
patients and implementation of the educational intervention. The post-interventional 
data were available from 120 patients of interventional group and 144 patients of 
control group. Hypertension related knowledge, medication adherence, and Health 
Related Quality of Life scores were significantly associated (p<0.001) when 
compared between interventional and control group at the completion of the 
intervention. There was an increase in mean knowledge score (10.26±1.11) as well as 
medication adherence (3.24±0.93). The interventional group however reported a 
noteworthy reduction in health status compared with the baseline analysis.  
 
In conclusion, the educational intervention by hospital pharmacists led to a 
significant increase in the patients’ levels of knowledge about hypertension and a 
positive impact on medication adherence. Therefore, the role of pharmacists in 
patient education must be formalized and acknowledged as an official part of the 
healthcare system. 
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 CHAPTER ONE: GENERAL INTRODUCTION 
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1.1 Background to research 
Since centuries, life on earth has faced its greater adversary; ‘communicable 
diseases’. Life expectations and standards were deprived due to the uncontrolled and 
unforeseen epidemics. However, the end of World War II started a new era for 
human beings. The progression of medical research, development of high end 
medicines (antibiotics and vaccinations) and incorporation of hygienic measures into 
treatment regimens uplifted the standards of managing communicable diseases 
(Omran, 1971). The urbanization of the society resulted in improved social and 
economical standards, however; resulted in another menace of ‘non communicable 
diseases (NCDs)’. Diabetes, cardiovascular diseases, cancer, mental illnesses and 
respiratory disorders started becoming a burden in the developed countries (Khuwaja 
et al., 2011). By the dawn of the third millennium, NCDs were seen far-reaching the 
entire world, with an increasing ratio in developing countries. Within this context, 
NCDs represented 43% of the total disease burden in 2011 worldwide (World Health 
Organization, 2011). A rise of 60% in the frequency of NCDs with a projected death 
rate of 73% worldwide was also anticipated by year 2020 (World Health 
Organization, 2011).  
 
In addition to the mortality crisis, NCDs also have severe economic consequences. 
Patients spend their capital for medical care, governments spend it for public care 
and agencies spend it for the indemnity care. Findings from The World Bank 
revealed that China, India, and Britain will lose $558 billion, $237 billion, and $33 
billion, respectively, in national income as a result of largely preventable NCDs in 
the next 10 years (The World Bank, 2011). In addition, NCDs often ends either as 
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permanent disabilities or mortality, resulting in the loss of skilled and trained human 
resource which is another important economical loss. 
 
Within this context, NCDs are again reported as a major healthcare burden in 
Pakistan. Forty six percent of all deaths were accounted to NCDs in 2008 (World 
Health Organization, 2011). Cardiovascular diseases and mental illnesses were 
counted as major while respiratory diseases, cancers, and diabetes were reported as 
minor NCDs affecting population of Pakistan (The World Bank, 2011). Similar to 
what is reported around the world, hypertension (HTN) in Pakistan holds its 
prominent place among NCDs (Pakistan Medical Research Council, 1998). The 
treatment and management of HTN still poses severe challenges for the healthcare 
providers (HCPs) as HTN control around the world and as well as Pakistan is still far 
from optimal (Chobanian et al., 2003; Mohan & Campbell, 2009; Pakistan Medical 
Research Council, 1998; Shaikh, 2005; Svetkey et al., 2004).  
 
Effective treatment and management of HTN requires amalgamation of both 
pharmacological and non-pharmacological therapy (Katzung, Masters, & Trevor, 
2009; Taranikanti, Alriyami, & Banerjee, 2011). Whereas patients have no control 
over treatment regimen prescribed by the HCPs, they can manage the progression of 
HTN through lifestyle modifications (Svetkey et al., 2004; Whelton et al., 2002). In 
order to be indulged into self-management of HTN, patients need rational 
information and up-to-date education for effective self-management (Dubbert, 1995). 
The information sources that hypertensive patients can consult for lifestyle 
modifications are diverse (HCPs, healthcare centres, electronic, print or social media, 
friends and family members and peers). Among all, healthcare centres and HCPs are 
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the only reliable and unbiased source of information (Shiri, 2007). Unfortunately in 
developing countries, these two sources are not readily available to the general 
population. In addition, there is a shortage of healthcare centres and HCPs in most of 
the developing countries. This produces an additional burden on the existing 
healthcare resources. The available HCPs are therefore unable to give sufficient time 
to the address health care needs and patient education (World Health Organization, 
1998a). 
 
To overcome such issues, a number of patient education programs are advised both 
at the clinical and community level. Patient education programs are effective in 
increasing patients’ knowledge about their illnesses, modifying their beliefs towards 
medication use, alter the medication taking behaviour and thus improve health 
related outcomes. These programs can be built upon discussions, distribution of 
written information, e-learning, and oral presentations addressing patients as 
individuals, in groups or the community as a whole. 
 
1.2 Justification of the study 
In literature, a number of interventional strategies targeting patient education for the 
management of HTN are presented and reported. However, such exercises are 
developed and implemented in developed countries (Côté, Moisan, Chabot, & 
Grégoire, 2005; Gusmão, Mion Jr, & Pierin, 2009; Haynes, Ackloo, Sahota, 
McDonald, & Yao, 2008; Kripalani, Yao, & Haynes, 2007). Difference of socio-
economical status, lifestyle, habits, and cultural norms makes it nearly impossible to 
apply the reported measures in a developing country like Pakistan. Therefore, a 
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number of culturally-appropriate approaches were needed in Pakistan to educate 
patients about treatment and management of HTN. 
 
This study reports the outcomes of an educational interventional program offered to 
hypertensive patients through hospital pharmacists. For this interventional study, the 
role of pharmacist as an educator is defined, executed, evaluated and prioritized to 
meet the specific needs of the hypertensive patients. However, the role was defined 
with an intention that the intervention could be generically applied to other 
healthcare units. The basic philosophy was to elaborate advantages of integrating a 
pharmacist into a healthcare team and to serve as a stepping stone toward other 
clinically related investigations. 
 
1.3 Overview of thesis 
Chapter 2, the literature review, starts with definitions of patient education followed 
by an in-depth discussion about the theoretical models of patient education. The 
chapter continues with an overview of the medication adherence and its importance 
in patient reported outcomes. Further discussion in this chapter involves the 
aetiology, treatment, management of HTN. The literature review finishes with the 
discussion of Health Related Quality of Life (HRQoL), its conception and current 
status among hypertensive patients. A thorough review of literature relevant to the 
study, looking at patient education, medication adherence and HRQoL among 
hypertensive patients in Pakistan and elsewhere in the world forms the bulk of this 
chapter. 
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Chapters 3, 4, and 5 are consolidated as qualitative phase. Chapter 3 comprises a 
thorough discussion of the methodology used for the qualitative studies undertaken. 
Chapter 4 presents the findings from interviews conducted with hypertensive patients 
about their perceptions of medication use and treatment adherence in HTN. Chapter 
5 presents the findings from the focus group discussion (FGD) with hypertensive 
patients on the issues related to self-management of HTN.  
 
Chapters 6, 7 and 8 are consolidated as quantitative phase. This phase describes the 
pre- and post- interventional assessment of HTN related knowledge, medication 
adherence and HRQoL. Chapter 6 starts with a systematic discussion of the 
methodology used for conducting the study. The tools used for data collection, 
development of the interventional package, training of the pharmacists, 
randomization of the patients and implementation of the intervention are thoroughly 
discussed. Chapter 7 describes the pre-interventional findings i.e. the current level of 
HTN related knowledge, medication adherence and HRQoL. In chapter 8, the impact 
of the intervention is evaluated as post-interventional assessment. Chapter 9 draws 
the thesis to a conclusion with an overall summary and a set of recommendations for 
further research. 
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 CHAPTER TWO: LITERATURE REVIEW 
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2.1 Introduction 
The role of pharmacist in the healthcare system from product orientation to patient 
care had developed over the past two decades (Pronk et al., 2002; Tipnis, 2012; 
Whaley, 1999). Within this context, pharmacist role in primary care is becoming 
more eminent in developed world (Starfield, 1991). Ideally, primary care is a 
coordinated matrix system provided by a mix of healthcare professionals and offers a 
holistic approach towards prevention, treatment, management and prevention of 
illness. In addition, primary care also addresses other determinants (social and 
economical influences) of health (Care, 2003).  
 
Over the last decade, many publications have been published to support the role of a 
pharmacist as medication counsellor and educator in primary health care systems 
(Gandhi et al., 2003; Gilbody, Whitty, Grimshaw, & Thomas, 2003; Schnipper et al., 
2006). A number of trials had reported a positive and economical effect from 
hospital pharmacy services on patient reported outcomes, particularly in the areas of 
chronic disease management (Benavides, Rodriguez, & Maniscalco-Feichtl, 2009; 
Chisholm-Burns et al., 2010; Finley, Crismon, & Rush, 2003; Salgado, Moles, 
Benrimoj, & Fernandez-Llimos, 2012). Furthermore, addition of pharmacy services 
in education related to quality use of medication at the primary care level resulted in 
better patient safety, improved disease and drug therapy management, as well as 
improved adherence and quality of life (QOL) (Hammond et al., 2003; Kaboli, Hoth, 
McClimon, & Schnipper, 2006). 
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2.2 Patient education  
According to the charter of World Health Organization (WHO), “patients have the 
right to be given factual, supportable, understandable and appropriate information, 
to be provided in such a way as to allow them to decide whether they wish to receive 
therapy” (World Health Organization, 1994). Under this charter, HCPs are 
responsible to educate their patients in order to enable them to understand their 
conditions and the role of the prescribed therapy (Kessler, 1991; Kim, Ram, 
Klaukka, Alanko, & Kessler, 1992). Patient education is a basic component of 
healthcare and is being applied in clinical as well as non clinical settings (Falvo, 
2004; Hamad, 2009; Lorig, 2000).   
 
Patient education is defined as “planned and organized learning experiences aimed 
to assist controlled adoption of behaviours, skills, or beliefs advantageous to health” 
(Ryan, 2007). It is an important constituent of the healthcare system and is 
categorized into two components (Lorig, 2000): 
 
i. Clinical patient education (teaching and learning provided to patients in 
clinical settings).  
ii. Health education (wellness, prevention, and health promotion provided to 
individuals, groups, and communities) 
 
The objectives of patient education encircle patient’s assessment, appraisal, 
diagnosis, prognosis and requirements related to a specific intervention (Lenz, 
Steckelberg, & Muhlhauser, 2008). On the other hand, health education contemplates 
on wellness, prevention, and health support for the individual or the community. 
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Whatever the nature of patient education is, the motive encompasses changing and 
improving societal health behaviours. Patient education results in improving health 
literacy which is a considerable societal issue. Improved health literacy is crucial at 
every level of illness management but is highly significant for persons living with 
chronic diseases because of more recurrent and complex interactions at all levels of 
healthcare system (U.S. Department of Health and Human Services, 2000).  
 
Health literacy is defined as “the extent to which individuals attain, practice, and 
appreciate basic health information and services needed to make apposite health 
decisions” (U.S. Department of Health and Human Services, 2000). The WHO 
defines health literacy as “the cognitive and social skills which determine the 
motivation and ability of individuals to gain access to, understand, and use 
information in ways which promote and manage good health” (World Health 
Organization, 1998b).   
 
Health literacy is crucial in the present era, as patients are actively involved in 
healthcare decisions and are eager to know ‘more’ about their conditions (McQueen, 
2001). Today, the illness-based approach is replaced with risk-based strategies thus 
enabling patients as associates of concern along with their HCPs (Dreeben-Irimia, 
2010). However, the extent to which these risk taking activities are abridged depends 
upon patient’s own understanding of risk and change. Within this context, several 
health behaviour models and theories have been proposed to understand an 
individual’s health-related behaviour. Therefore, patients’ belief and perception 
towards illness are important to consider before developing and implementing an 
educational package both at the institutional as well as community level.  
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2.2.1 Health Belief Model 
Perhaps, the best known model in public health is the Health Belief Model (HBM). 
Introduced in early 1970s, HBM helps in understanding human behaviour towards 
health services (Becker, 1974). The model's four key components are conceptualized 
as perceived susceptibility, perceived severity, perceived benefits, and perceived 
barriers. ‘Cues to action’ is another construct of HBM which helps in the 
understanding of actions that trigger human behaviour (Weinstein, Rothman, & 
Sutton, 1998). The model assumes that an individuals’ health behaviour depends 
upon the belief about the impact of the illness and its consequences, provided that the 
individual has a distinct course of action by which to proceed. It is important to 
understand how vulnerable a person considers him- or herself in getting a disease, 
how serious the disease symptoms are for an individual, and how beneficial the 
suggested course of action is considered to be. A lack of emphasis on these factors 
may result in a poor response towards patient educational programs and hence can 
shape up as a complete failure. According to the HBM, an individual will always 
indulge into a cost benefit analysis and based on the analysis, he/she will select the 
most suitable option available (Becker, 1974). Demographic, cultural, psychological, 
and personality have a strong influence on an individual while coming up to a 
decision. For example, even though the benefits of regular exercise in HTN and 
cardiovascular diseases are universally accepted (Buttar, Li, & Ravi, 2005), many 
barriers prevent individuals from exercising (no time, expensive, non-appropriate 
settings). In addition to the extrinsic barriers outlined earlier, there are intrinsic 
barriers to exercise (difficulties, pain, limited interest etc) which are responsible for a 
specific behaviour towards exercise (Buttar et al., 2005). Likewise, among patients 
who perceive their treatment as ‘vulnerable to complications’ can decide not they 
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take their medication which decreases their adherence to therapy and overall HRQoL 
(Vermeire, Hearnshaw, Van Royen, & Denekens, 2002). Therefore, it is vital to 
highlight illness perception of the population before designing and implementation of 
the educational program. Within this context, the use of qualitative research can 
provide in-depth knowledge concerning perceptions, beliefs and values of an 
individual or groups and have proved to be valuable (Curry, Nembhard, & Bradley, 
2009; Kotzeva et al., 2010). In addition, qualitative methods extract out the reasons 
that why individual or groups hold the particular views and ideas. Consequently, 
conducting a qualitative inquiry before designing and implementation of educational 
interventions can provide rich information on the patient’s needs for designing of 
such interventions. 
 
2.2.2 The Theory of Planned Behaviour 
Icek Ajzen in 1991 presented the possibility of a relation between an individual’s 
attitudes and behaviour (Ajzen, 1991). The theory is widely used to demonstrate the 
correlation among beliefs, attitudes, behavioural intentions and behaviours in social 
and health sciences. The theory also highlights that societal approaches and norms 
are the influencing factors that forces individual to opt an action which in turn is 
reflected in shape of behaviour (Ajzen, 1991). For example, Faber and Kruger 
highlighted a common belief that when a married woman in Africa starts losing 
weight, the intention is to attract the attention of other men besides her husband 
(Faber & Kruger, 2005). In addition, Puoane et al reported that weight gain among 
females is a reflection of husband’s excellent care for his wife and family (Puoane et 
al., 2012). Therefore, as maintaining weight is a societal norm, weight loss is 
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considered a bad practice even in the presence of HTN, diabetes, obesity and other 
cardiovascular disorders.   
 
Within this context, Peters and colleagues employed the theory of planned behaviour 
as a guide to explore perceptions and beliefs of African Americans towards 
prevention of HTN (Peters, Aroian, & Flack, 2006). The authors mentioned that 
healthcare professionals should be cognizant of the influence of societal and cultural 
factors on individual behaviour. Elaboration and influences of societal and cultural 
norms should be expanded to family and community members before designing 
patient’s educational plans in order to improve HTN control. The interventions 
should particularly target the cultural and societal norms so that such interventions 
can improve preventive behaviours and decrease the disparity in HTN control and 
outcomes (Peters, Aroian, & Flack, 2006). 
 
Nevertheless, it is not a simple task to alter societal and cultural beliefs as long as the 
community is not well informed about the health risks and hazards. In addition, 
individuals interested opting a particular behaviour can find it difficult because of the 
societal pressure and cultural hindrance. One possible method to overcome the 
societal and cultural pressure is by bringing along the involvement of influential 
community members, religious leaders or social workers that can disseminate the 
message which is the core objective of the educational campaign.  
 
2.2.3 The Common Sense Model of Illness Representation 
The common sense model (CSM) highlights individual himself/herself as a problem 
solver. The CSM is centred on the perceived reality of the health hazard and 
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emotional reactions to this threat (Cameron & Leventhal, 2012; Diefenbach & 
Leventhal, 1996). According to CSM, a stimulus evoking illness illustrations can be 
either internal or external.  In both cases, the toning process circulates around five 
discrete characteristic of illness: identity, timeline, cause, controllability, and 
consequences. The identity reflects general know how of the disease/condition and 
associated signs and symptoms. The timeline connects the disease/condition to a 
predictable timeframe. These two fundamental traits than defines the expected cause 
of the disease/condition. The professed controllability of the stimulus than defines 
the common sense meaning followed by a set of imagined consequences or 
predictable ramifications of the disease/condition which is the actual reason for the 
specific behaviour (Cameron, Leventhal, & Leventhal, 1993; Hagger & Orbell, 2003; 
McAndrew et al., 2008).  
 
A classical example of CSM is provided by Meyer and colleagues by interviewing 
230 hypertensive patients (Meyer, Leventhal, & Gutmann, 1985). The respondents 
were sufficiently aware of the sign and symptoms of HTN and suggested a 
developmental progression in the condition over time. This is against to the general 
ideology of HTN where in major cases, HTN is considered as an asymptomatic 
condition. Majority of the patients were familiar with the chronic model of HTN and 
reported “lifetime treatment” for their condition. Seventy five to 80% of the patients 
had ideas about the cause of their condition. Majority of the patients perceived their 
condition as controllable and were in favour of continuing treatment. Therefore, the 
authors concluded that when an individual develops intrinsic beliefs about disease 
threats; these threats are responsible to guide to a specific behaviour representing 
HTN as chronic yet controllable condition (Meyer et al., 1985). 
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2.2.4 Structure of patient education 
Patient education package depends on patients’ perceptions of their illness, 
understanding of the cause, prognosis, medication (treatment and management) and 
lifestyle elements (Koo, Krass, & Aslani, 2003; Wade, Weir, Cameron, & Tett, 
2003). For instance, it is now known that patients who are less aware of chronic 
diseases like diabetes and HTN can develop complications as compared to those with 
better understanding of (El-Shazly, Zeid, & Osman, 2000; Zafar, Gowani, Irani, & 
Ishaq, 2008). In another study among hypertensive patients, patients who were less 
knowledgeable about their condition were found non adherent to the therapies and 
vulnerable to the impediments (Patel & Taylor, 2002). Therefore, information 
provided to the patients/persons on medical therapies must contain the name, 
intention, directions, storage instructions, possible side effects, adverse effects that 
necessitate medical consideration, duration of treatment and contraindications (Dyck, 
Deschamps, & Taylor, 2005; Hermann, Herxheimer, & Lionel, 1978). Lack of 
sufficient information in these areas can lead to inappropriate use of medications 
resulting in the development of further complications (Oparil & Calhoun, 1998). 
However, such incidences are avoidable through a comprehensive and detailed 
patient educational programme (Hornung, Kieserg, Feldmann, & Buchkremer, 1996; 
Saounatsou et al., 2002; Zwaenepoel et al., 2005). In addition to medication related 
information, education on lifestyles modifications also helps the patients/persons to 
avert their conditions from aggravation. For example, hypertensive patients are often 
encouraged to quit tobacco use, unhealthy diets, excessive alcohol and adopt some 
kind of physical activity (Botelho, 2004; Duangtep, Narksawat, Chongsuwat, & 
Rojanavipart, 2010; Woolf, Jonas, & Kaplan-Liss, 2007).  
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There are varieties of methods of providing patient education programmes. Patients 
can be involved by the use of oral presentations or discussions as an individual, 
groups or the community as a whole (Fitzmaurice & Adams, 2000; Hacihasanoğlu & 
Gözüm, 2011; Mazzuca et al., 1986). Such educational measures are also improved 
with written information which enables patients/persons to maximum information 
(Buck, 1998; Vander Stichele, Van Haecht, Braem, & Bogaert, 1991). Audiovisuals 
and online methods are also used to educate patients (Kripalani et al., 2007; Misono 
et al., 2010). 
 
An important yet neglected aspect of patient education is its continuous nature. 
Healthcare providers should provide incessant teaching to the patients as the later is 
not a once-off procedure. This strengthens the guidance patients received during their 
previous visits. Another important feature of providing patient education is the 
timing of information provision. For example, an anxious patient on the first visit can 
never comprehend to the instructions and information provided by the HCPs (Goold 
& Lipkin, 1999). The repetition of information during the following visits can help in 
recalling the missed information and can help the patients in better understanding, 
management and control of their condition (Shiri, 2007). 
 
2.2.5 Patient education and the role of HCPs 
Patient education is a basic right of the patients and healthcare members are bound to 
provide such information. Healthcare providers should provide pertinent yet enough 
information to the patients thus avoiding the development of confusion. Failure in 
providing ample edification will result in obtaining information from other sources, 
such as mass media, friends and peers, family members and internet. However, the 
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authenticity of such information is always questionable. Therefore, to avoid such 
calamities, healthcare professionals must educate their patients so they can receive 
appropriate information (Kreitzer, Kligler, & Meeker, 2009).  
 
Within this context, pharmacists are best suitable for the role of educating patients. 
Being custodian of medicines, a pharmacist is the last healthcare professional which 
will be seen by patients before heading home (Awofisayo, Awofisayo, Iferi, & 
Akpan, 2008). Therefore, it is vital that pharmacists should be well prepared and 
trained in providing education to the patients. Other than described, following 
competencies are expected from pharmacists in providing patient education (Burke et 
al., 2008): 
 
i. Converse caringly with patients. 
ii. Identify the needs of patients.  
iii. Consider the patients’ emotional state, their understanding and account of the 
disease and its treatment. 
iv. Help patients to learn and understand their diseases. 
v. Educate patients in managing their treatment within available health, social 
and economic resources. 
vi. Help patients to handle their way of life. 
vii. Educate and advise patients on the management of catastrophe and of issues 
that hamper with the normal management of their condition. 
viii. Select patient education tools and procedures. 
ix. Periodically assess and advance the educational performance of health care 
providers by means of continuous medical educational campaigns. 
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2.2.6 The role of patient education in HTN 
The lifelong nature of HTN places a number of challenges for the HCPs. Difficulty 
in designing a superlative treatment regimen for the patient, minimization of side 
effects, and non adherence to medication are the most frequent problems faced 
during the course of treatment (World Health Organization, 2009). Furthermore, the 
biggest confrontation faced by the HCPs is to motivate patients to espouse lifestyle 
modifications and to continue with it (Appel et al., 2003; Elmer et al., 2006). 
Therefore, patient education is an important tool to empower hypertensive patients to 
make decisions about their condition. This helps the patients to draw value for 
treatment adherence as well as supportive therapies.  
 
Within this context, patient education also helps to alter perceptions and beliefs of 
the patients. Patient education is responsible in an increase in patient’s understanding 
of their condition. This in result builds a more productive and positive attitude 
towards HTN, prescribed therapy and management (Viswanathan, Anderson, & 
Thomas III, 2005). When patients’ beliefs and perceptions are altered, the 
implemented interventions results in adequate health outcomes. However, 
establishing patients’ beliefs and perceptions is not an easy task, as some are hesitant 
to express their views and opinions. In such cases, family members, peers or friends 
should be involved in the educational program so they can influence the patients 
reluctant to change and adopt new behaviour and lifestyle modifications.  
 
2.2.7 Barriers to patient education 
Certain barriers are faced by the HCPs that can make the flow of education difficult 
for the patient or the community. Factors such as lack of resources, competency, 
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financial constrains and workforce is the most commonly faced barriers in providing 
patient education (Ling, Brereton, Conklin, Newbould, & Roland, 2012; Penz et al., 
2007). In addition, healthcare members sometimes are not willing to educate the 
patients. For instance, pharmacist can have reservations in informing their patients 
about potential side effects, which in turn can decrease the adherence to the regimen 
(Kessler, 1991). Often at times, patient education is provided by healthcare members 
that lack proper training, with little experience, poor communication skills or 
deprived knowledge which again act as a barrier in providing education to the patient 
(Dickson, Hargie, & Morrow, 1996). Another obstacle which is commonly observed 
is the lack of coordination and collaborative care among healthcare members (Baggs 
& Schmitt, 2007). Furthermore, HCPs from different institutes can have different 
views which can hinder the benefits of patient education (Deccache & Aujoulat, 
2001). Another important barrier to patient education is the language differences 
between HCPs and patients (Flores, 2006). All of the mentioned barriers can have 
deleterious effects on overall therapy and results in decreased patient satisfaction. 
Therefore, it is vital to overcome all such barriers before implementing an 
educational plan for the patients. 
 
2.3 Adherence 
The term adherence is defined as “ the extent to which a person’s behaviour, taking 
medication, following a diet, and/or executing lifestyle changes corresponds with 
agreed recommendations from a health care provider” (World Health Organization, 
2009).  
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In general, the word ‘adherence’ depicts that healthcare providers and patients are in 
agreement when it comes to disease related decisions (Osterberg & Blaschke, 2005).  
The terms compliance and concordance are also used as a synonym with adherence. 
However, adherence is an active approach and suggests positive association as 
compared to compliance which portrays patients as passive recipients of instructions 
(Friberg & Scherman, 2005). Concordance on the other hand, involves equal 
partnership between healthcare providers and patients in building medication-taking 
behaviour (World Health Organization, 2009). Nevertheless, patients do not always 
participate actively during consultations and leave everything on the HCPs. In both 
cases, the word compliance and concordance are less impressive and adherence is 
more suitable because of the patient’s correspondence which makes an active 
participation of all players of the healthcare system (Osterberg & Blaschke, 2005). 
 
2.3.1 Theoretical explanations for medication adherence  
In literature, certain models have been proposed that attempt to explain adherence 
among patients and are discussed subsequently: 
 
2.3.1(a) Health Belief Model and its connectivity with treatment adherence  
According to HBM, patient’s adherence to the treatment plan is based upon their 
inclination in such a manner that results in the improvement of their conditions 
(Maiman & Becker, 1974).  Nevertheless, this action is highly related to the beliefs 
and perceptions regarding the condition which patients carry. Therefore, perception 
and beliefs have a greater inventive influence as compared to the reality which in 
actual constructs the explanation of a particular behaviour (Hurley, 1990). 
 21
Cerkoney and Hart stated that behavioural change is a three stepped process 
(Cerkoney & Hart, 1980). The first step is readiness for change which is followed by 
a comparison of pros and cons. This comparison is only made when an individual is 
equipped with enough information to understand that why a behavioural change is 
needed. Finally, cues (either internal or external) are developed which results into a 
particular behaviour change. Within this context, hypertensive patients visiting HCPs 
will always compare the recommendations against their perceived outcomes which in 
return can affect medication adherence. This readiness of change depends upon the 
level of motivation (internal and external) but necessitates a noteworthy support from 
the surroundings. Hence to initiate a positive shift in adherence among hypertensive 
patients, it is vital to address patients’ perceptions about their illness and treatment 
regimens. Only then, a positive shift in treatment adherence will be observed which 
can improve patients’ HRQoL and improvement in treatment and management of 
HTN. 
 
The HBM is further extended by Rosenstock who connected treatment adherence to 
six different attributes. The first trait is motivation (i.e. individuals are aware of their 
condition and are interested in improving their health and health related behaviours). 
The second characteristic is perceived vulnerability to a disease or illness. Third, the 
individual should have information about the nature (severity) of their condition. 
This is followed by involvement in an intervention based upon its perceived benefits. 
The fifth attribute is the individual’s perceived barriers to taking action. Lastly, the 
individual must have knowledge of the condition and the treatment prescribed to 
him.  
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After a review of the current literature, HBM is predominantly applicable to 
adherence issues in individuals with HTN (Garfield & Caro, 1999; Ross, Walker, & 
MacLeod, 2004). The authors declare that not only HCPs have to provide direct 
treatment interventions, but they should also address patients’ concerns, beliefs and 
potential barriers to adherence regarding their medication regimens. 
 
2.3.1(b) Transtheoretical model and its connectivity with treatment adherence 
The best connection among adherence and human beliefs and perceptions is provided 
by the transtheoretical model (TTM). The TTM evaluates an individual's willingness 
to act on a new healthier behaviour, and provides strategies, to guide the individual 
through the stages of change (Prochaska et al., 1994).  
 
The TTM is basically an integration of other health related models. It was reported 
that TTM was highly efficient in promoting health behaviours when coupled with 
other models (Prochaska et al., 1994). This model attempts to conserve ideologies 
that are effective in behaviour change by encouraging treatment programs to be 
inventive and modified. This is achieved by concentrating upon patient’s individual 
needs. One aspect of TTM revolves around processes of change, which are 
behaviours performed by individuals to change their thinking and behaviour. In 
quintessence, TTM suggests that tailoring to individual needs will be achieved by 
matching the individual’s process of change. The process includes stage of pre-
contemplation, where the patient is not thinking about behaviour change. This is 
followed by contemplation where the patient begins to think about behaviour change. 
The next stage is preparation where patient prepares to make the behaviour change. 
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Lastly, in order to continue the modifications, patients enter into the maintenance 
phase (Prochaska & Norcross, 2009). 
 
With this context, Chang and colleagues discussed the behavioural change for blood 
pressure control among hypertensive patients in Taiwan (Chang, McAlister, Taylor, 
& Chan, 2003). The authors reported that rural population faced more difficulties 
than the urban population in avoiding smoking and engaging in physical activity. 
One possible reason proposed is the probability of process of change being used by 
the rural population was significantly lower than the urban population. Furthermore, 
after HTN diagnosis, individuals in the urban area shifted from the pre-
contemplation stage to the maintenance stage for HTN control. Similar to what is 
reported earlier, Johnson et al reported about the capability of a theoretically driven, 
TTM-based computerized system to improve adherence in hypertensive patients 
(Johnson et al., 2006). The authors reported that cost-effective, evidence-based 
interventions should be offered to all patients at all level of readiness for change.  
 
2.3.1(c) Self regulation Model and its connectivity with treatment adherence 
The self regulation model (SRM) in relation to social learning theory defines the 
position and means of an individual’s behaviour when presented with health advice 
(Haynes et al., 1982). The SRM consists of the following components: 
 
i. Extraction of information from the environment. 
ii. Creating a depiction of the illness danger to oneself. 
iii. Planning and acting to handle the problem and to take selective measures. 
iv. Observing and monitoring the reaction of the problem  
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The SRM assures understanding and modifying adherence among patients (Haynes 
et al., 1982). According to the postulations of the SRM, sign and symptoms are an 
important variable for development of illness representations and action behaviours. 
When a disease is present, patients normally will try to search for cause of illness and 
correspond accordingly (Leventhal, Brissette, & Leventhal, 2003). From a 
biomedical viewpoint, HTN being asymptomatic requires long term adherence to 
treatment to avoid cardiovascular events. However, it was reported that because 
hypertensive patients do not report symptoms, such experiences negatively affects 
treatment adherence (Kjellgren, Svensson, Ahlner, & Säljö, 1998; Kyngäs & 
Lahdenperä, 2001). Moreover, some patients are in position of describing their 
symptoms based upon the level of increased degree of blood pressure and can change 
their medication taking behaviour (Chen, Tsai, & Lee, 2009).  
 
Symptoms and core ascriptions play an important role in psychopathological 
processes, adaptation of health behaviours such as adherence and can effect illness 
representation. Chen and colleagues reported that hypertensive patients are more 
likely to be motivated to adhere to prescribed medications if they believe that 
treatment may bring beneficial effects to their situation (Chen et al., 2009). In 
addition, perception of a patients’ aptitude to manage illness representation is also a 
key determinant of adherence to health recommendations (French, Cooper, & 
Weinman, 2006). In the light of above findings, SRM provides a constructive 
framework for understanding and explaining adherence to therapeutic regimens of 
patients with HTN.   
 
